Search results
- 1.0552726 - ÚOCHB 2022 RIV CZ eng J - Journal Article
Vonka, V. - Hirsch, Ivan
Prophylactic vaccines against cancers of non-infectious origin: a dream or a real possibility?
Central European Journal of Public Health. Roč. 29, č. 4 (2021), s. 247-258. ISSN 1210-7778. E-ISSN 1803-1048
Institutional support: RVO:61388963
Keywords : cancer * prophylactic vaccines * proto-oncogenes RAS and RAF
OECD category: Virology
Impact factor: 1.154, year: 2021
Method of publishing: Open access
https://doi.org/10.21101/cejph.a7219
Permanent Link: http://hdl.handle.net/11104/0327841 - 2.0192749 - UOCHB-X 970051 RIV CZ eng J - Journal Article
Kitasato, H. - Tardy-Kadlec, A. - Šmahel, M. - Tykva, Richard - Vonka, V.
Putative Regulatory Sequence in Human Papillomavirus Type 16 E2 Open Reading Frame.
Folia Biologica. Roč. 43, č. 1 (1997), s. 41-44. ISSN 0015-5500. E-ISSN 0015-5500
R&D Projects: GA ČR GA312/94/0890; GA MZd G-1914-3
Impact factor: 0.522, year: 1997
Permanent Link: http://hdl.handle.net/11104/0088473 - 3.0191680 - UMG-J 20033195 RIV GR eng J - Journal Article
Mikyšková, Romana - Indrová, Marie - Šímová, Jana - Jandlová, Táňa - Bieblová, Jana - Jinoch, P. - Bubeník, Jan - Vonka, V.
Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: cytokine and gene therapy with IL-2 and GM-CSF.
International Journal of Oncology. Roč. 24, č. 1 (2004), s. 161-167. ISSN 1019-6439. E-ISSN 1791-2423
R&D Projects: GA MZd NC7148; GA MZd NC7552; GA ČR GA301/01/0985
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV16 * gene therapy * minimal residual tumour disease
Subject RIV: FD - Oncology ; Hematology
Impact factor: 3.056, year: 2004
Permanent Link: http://hdl.handle.net/11104/0087418 - 4.0191679 - UMG-J 20033194 RIV GR eng J - Journal Article
Bubeník, Jan - Mikyšková, Romana - Reiniš, Milan - Mendoza, Luis - Indrová, Marie - Šmahel, M. - Vonka, V.
Cytokines and dendritic cells as adjuvants for therapy of HPV16-associated tumours.
International Journal of Molecular Medicine. Roč. 12, Supplement 1 (2003), s. S7. ISSN 1107-3756. E-ISSN 1791-244X.
[The 8th World Congress on Advances in Oncology and 6th Internationl Symposium on Molecular Medicine. Hernissos, Crete, 16.10.2003-18.10.2003]
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV16 * dendritic cells * cytokines
Subject RIV: FD - Oncology ; Hematology
Impact factor: 1.940, year: 2003
Permanent Link: http://hdl.handle.net/11104/0087417 - 5.0191677 - UMG-J 20033192 RIV NL eng J - Journal Article
Bubeník, Jan - Vonka, V.
MHC class I status of tumours and design of immunotherapeutic strategies.
Immunology Letters. Roč. 90, 2-3 (2003), s. 177-178. ISSN 0165-2478. E-ISSN 1879-0542
R&D Projects: GA MZd NC7148; GA MZd NC3707; GA MZd NC6957; GA MZd NC7552; GA ČR GA301/01/0985; GA AV ČR IAA5052203
Institutional research plan: CEZ:AV0Z5052915
Keywords : MHC * beta2-mikroglobulin * immunotherapeutic strategies
Subject RIV: FB - Endocrinology, Diabetology, Metabolism, Nutrition
Impact factor: 1.710, year: 2003
Permanent Link: http://hdl.handle.net/11104/0087415 - 6.0191666 - UMG-J 20033177 RIV CZ eng J - Journal Article
Šímová, Jana - Mikyšková, Romana - Vonka, V. - Bieblová, Jana - Bubeník, Jan - Jandlová, Táňa
MHC class I+ and class I(-)HPV16-associated tumours expressing the E7 oncoprotein do not cross-react in immunization/challenge experiments.
Folia Biologica. Roč. 2003, č. 49 (2003), s. 230-234. ISSN 0015-5500. E-ISSN 0015-5500
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV 16 * MHC class I expression * tumour vaccines
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 0.527, year: 2003
Permanent Link: http://hdl.handle.net/11104/0087404 - 7.0191663 - UMG-J 20033174 RIV CZ eng J - Journal Article
Indrová, Marie - Mikyšková, Romana - Jandlová, Táňa - Vonka, V. - Bubeník, Jan - Bieblová, Jana
Adjuvant cytokine treatment of minimal residual disease after surgical therapy in mice carrying HPV16-associated tumours: Cytolytic activity of spleen cells from tumour regressors.
Folia Biologica. Roč. 2003, č. 49 (2003), s. 217-222. ISSN 0015-5500. E-ISSN 0015-5500
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV16 * gene therapy * IL-2
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 0.527, year: 2003
Permanent Link: http://hdl.handle.net/11104/0087401 - 8.0191662 - UMG-J 20033173 RIV GR eng J - Journal Article
Indrová, Marie - Bubeník, Jan - Mikyšková, Romana - Vonka, V. - Šmahel, M. - Žák, R. - Šímová, Jana - Bieblová, Jana - Mendoza, Luis - Jandlová, Táňa
Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin.
International Journal of Oncology. Roč. 2002, č. 20 (2002), s. 643-646. ISSN 1019-6439. E-ISSN 1791-2423
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV16, IL-2 * tumour vaccines * gene therapy
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 2.931, year: 2002
Permanent Link: http://hdl.handle.net/11104/0087400 - 9.0191584 - UMG-J 20033052 RIV NL eng J - Journal Article
Bubeník, Jan - Mikyšková, Romana - Vonka, V. - Mendoza, Luis - Šímová, Jana - Šmahel, M. - Indrová, Marie
Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16.
Vaccine. Roč. 21, 9-10 (2003), s. 891-896. ISSN 0264-410X. E-ISSN 1873-2518
R&D Projects: GA MZd NC7148; GA ČR GA301/00/0114; GA ČR GA301/01/0985; GA AV ČR IAA7052002; GA AV ČR IAA5052203
Grant - others:Liga proti rakovině(CZ) -
Institutional research plan: CEZ:AV0Z5052915
Keywords : interleukin-2 * HPV 16 * dendritic cells
Subject RIV: FD - Oncology ; Hematology
Impact factor: 3.007, year: 2003
Permanent Link: http://hdl.handle.net/11104/0087326 - 10.0191583 - UMG-J 20033050 RIV GR eng J - Journal Article
Mendoza, Luis - Bubeník, Jan - Šímová, Jana - Jandlová, Táňa - Vonka, V. - Mikyšková, Romana
Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV16-associated tumours.
International Journal of Oncology. Roč. 23, č. 1 (2003), s. 243-247. ISSN 1019-6439. E-ISSN 1791-2423
R&D Projects: GA MZd NC7148; GA ČR GA301/01/0985; GA AV ČR IAA5052203
Grant - others:Liga proti rakovině(CZ) -
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV 16 * dendritic cells * residual tumour disease
Subject RIV: FD - Oncology ; Hematology
Impact factor: 2.536, year: 2003
Permanent Link: http://hdl.handle.net/11104/0087325